Get ready to energize your life?
Top Offers Only Today
Support your health and step-up your mental focus
post in: Lifestyle, Health Date:17 Oct 2017, 09:05 views:3569
Five research programmes on health issues including cancer, housing, otoxin exposure feature in funding announced in June by the Health Research Council. The Centre for Public Health Research (cphr) has been funded to study whether endotoxin exposure can reverse atopy and atopic disease.
The four-year project has been funded 409,715. Those involved are Dr Jeroen Douwes, Dr Christine van Dalen, Dr Lis Ellison-Loschmann, David J McLean, and Professor Neil Pearce (all from northwest cphr and Professor Graham Le Gros (Malaghan Institute of Medical Research). The study involves a prospective cohort of previously unexposed allergic adults who are starting a career in industries with moderate to high endotoxin exposures.
Allergies, asthma, lung function, immune status and endotoxin exposure will be monitored upon start of employment and followed annually for a period of two years to see if endotoxin exposure can reverse atopy and atopic asthma.
The Centre has also been funded 120,000 over three years to study cancer in Pacific populations.
Researchers involved are Dr Sunia Foliaki, Dr Mona Jeffreys, Dr Lis Ellison-Loschmann, Dr Ate Moala, Professor Neil Pearce (all from cphr Professor George Davey Smith (University of Bristol Dr Siale Akauola (Ministry of Health, Tonga Dr Paolo Boffetta (International Agency for Research on Cancer, Lyon.
The research involves descriptive yses of cancer incidence and mortality in four Pacific countries (Tonga, Samoa, Fiji, and Niue) and in Pacific people in New Zealand, as well as a case-control study of breast cancer in women which will be conducted in the same four. Dr Stephen Stannard of the Institute for Food, Nutrition and Human Health, Associate Professor Campbell Thompson of the Flinders Medical Centre in South Australia, and Professor Chris Cunningham of the Centre for Public Health Research will research insulin resistance, muscle triglyceride and Mäori.
Professor Neil Pearce will work with Professor Innes Asher, Alistair Stewart, Professor Edwin Mitchell, Professor Richard Beasley, of the Department of Paediatrics at asthma the University of Auckland, on isaac phase three ysis, publication and dissemination.
The project is for two years, with funding of 790,756. Professor Chris Cunningham will collaborate with Associate Professor Philippa Howden-Chapman, Professor Julian Crane, and Dr Michael Baker of the Department of Public Health, Wellington School of Medicine, University of Otago, on a housing and health research programme. The programme has been funded for three years, for.65 million.